# reload+after+2024-01-19 22:47:36.626706
address1§171 Oyster Point Boulevard
address2§Suite 500
city§South San Francisco
state§CA
zip§94080
country§United States
phone§650 825 6900
website§https://www.tenayatherapeutics.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy; TN-301, a small molecule for heart failure with preserved ejection fraction; and TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy. It also develops an adeno-associated virus-based gene therapy designed to deliver the dwarf open reading frame gene in the heart for dilated cardiomyopathy; and reprogramming program for cardiac regeneration to replace heart cells lost in patients experiencing heart failure due to prior myocardial infarction. The company was incorporated in 2016 and is headquartered in South San Francisco, California.
fullTimeEmployees§141
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Faraz  Ali M.B.A.', 'age': 50, 'title': 'CEO, Secretary & Director', 'yearBorn': 1973, 'fiscalYear': 2022, 'totalPay': 816387, 'exercisedValue': 0, 'unexercisedValue': 573750}, {'maxAge': 1, 'name': 'Dr. Deepak  Srivastava M.D.', 'age': 57, 'title': 'Scientific Founder, Chairman of Scientific Advisory Board & Director', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 118000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Timothy  Hoey Ph.D.', 'age': 64, 'title': 'Chief Scientific Officer', 'yearBorn': 1959, 'fiscalYear': 2022, 'totalPay': 573003, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Whittemore G. Tingley M.D., PH.D.', 'age': 55, 'title': 'Chief Medical Officer', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 621975, 'exercisedValue': 0, 'unexercisedValue': 92250}, {'maxAge': 1, 'name': 'Dr. Eric N. Olson Ph.D.', 'title': 'Scientific Founder & Member of Scientific Advisory Board', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Bruce R. Conklin', 'title': 'Scientific Founder', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Saptarsi  Haldar M.D.', 'title': 'Scientific Founder', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Sheng  Ding Ph.D.', 'title': 'Scientific Founder', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Benoit G. Bruneau Ph.D.', 'title': 'Scientific Founder', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Leone D. Patterson M.B.A.', 'age': 60, 'title': 'Chief Financial & Business Officer', 'yearBorn': 1963, 'fiscalYear': 2022, 'totalPay': 448545, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§8
boardRisk§5
compensationRisk§8
shareHolderRightsRisk§8
overallRisk§7
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§2.471
currency§USD
dateShortInterest§1702598400
forwardEps§-1.7
exchange§NMS
quoteType§EQUITY
shortName§Tenaya Therapeutics, Inc.
longName§Tenaya Therapeutics, Inc.
firstTradeDateEpochUtc§1627651800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§2244c099-c937-391d-9d2b-ae91c15b1439
gmtOffSetMilliseconds§-18000000
targetHighPrice§40.0
targetLowPrice§7.0
targetMeanPrice§19.14
targetMedianPrice§18.0
recommendationMean§1.9
recommendationKey§buy
numberOfAnalystOpinions§7
quickRatio§6.283
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
